18 Jun 2021 On Wednesday the 15th of June 2021, we held our Annual General Meeting to conclude our year and discuss about the future. Exciting time.
26 Apr 2021 The prestigious Shanghai ranking gives at Karolinska Institutet the fifth position in the world of the best Departments of Pharmacology worldwide
19 Apr 2021 Science Advances, has published a research article describing our proteomics technology AbiProt®, a high-tech antibody discovery approach with the potential to bring several novel antibody medicines to large patient populations in multiple disease areas.
11 Mar 2021 On March 10th 2021, Professor Owe Orwar, CEO presented Oblique Therapeutics AB at Carnegie Nordic Virtual Healthcare Seminar 2021.
08 Oct 2020 Oblique Therapeutics AB together with collaborators at Sahlgrenska University Hospital (Gothenburg) and Karolinska Institutet (Stockholm) has been granted 5MSEK by Vinnova to develop neutralizing antibodies towards SARS-CoV-2 and to develop its Abiprot platform into a first-line-of-defence for future pandemics.
21 Sep 2020 24th Sept 2020 – Oblique Therapeutics is delighted to be invited to speak at “Biopharma Conclave 2020”
